abrdn Life Sciences Investors Shares of Beneficial Interest financial statements, including revenue, expenses, profit, and loss

The total revenue of HQL for the last semiannual is 29.56 M USD, and it's 201.03% higher compared to the previous semiannual. The net income of H2 23 is -11.45 M USD.